# BELLUS Health Inc. (BLU)

Source: https://www.quantisnow.com/company/BLU
Generated: 2026-11-16T16:59:31.400Z

- Ticker: BLU
- Exchange: NASDAQ
- Sector: Health Care
- Industry: Biotechnology: Pharmaceutical Preparations
- IPO year: 2019
- Website: bellushealth.com

## About

BELLUS Health Inc., a clinical stage biopharmaceutical company, develops therapeutics for the treatment of chronic cough and other hypersensitization disorders. Its lead drug candidate includes BLU-5937, an oral small molecule antagonist of the P2X3 receptor, which is in Phase II clinical trial for treatment of chronic cough and chronic pruritus. The company was founded in 1993 and is headquartered in Laval, Canada.

## Latest BLU news and filings

- 2024-01-30 15:56 UTC [SEC Schedule 13G] [SEC Form SC 13G filed by BELLUS Health Inc.](https://www.quantisnow.com/insight/sec-form-sc-13g-filed-by-bellus-health-inc-5216521)
- 2023-08-14 21:01 UTC [SEC Schedule 13G] [SEC Form SC 13G/A filed by BELLUS Health Inc. (Amendment)](https://www.quantisnow.com/insight/sec-form-sc-13ga-filed-by-bellus-health-inc-amendment-4895970)
- 2023-07-10 12:00 UTC [SEC Form 15-12G filed by BELLUS Health Inc.](https://www.quantisnow.com/insight/sec-form-15-12g-filed-by-bellus-health-inc-4734090)
- 2023-07-07 17:18 UTC [Market Insight] [From AI to Obesity Drugs - Global Pharma Has $700B For M&A and Investments: Goldman Sachs](https://www.quantisnow.com/insight/from-ai-to-obesity-drugs---global-pharma-has-700b-4730948)
- 2023-06-28 21:20 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by BELLUS Health Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-bellus-health-inc-4698941)
- 2023-06-28 20:57 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by BELLUS Health Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-bellus-health-inc-4698662)
- 2023-06-28 18:42 UTC [SEC Form 6-K] [SEC Form 6-K filed by BELLUS Health Inc.](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-bellus-health-inc-4697291)
- 2023-06-28 15:05 UTC [SEC Form 6-K] [SEC Form 6-K filed by BELLUS Health Inc.](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-bellus-health-inc-4695951)
- 2023-06-28 14:57 UTC [Mergers & Acquisitions] [Stock-exchange announcement - For media and investors only - GSK completes acquisition of BELLUS Health](https://www.quantisnow.com/insight/stock-exchange-announcement---for-media-and-investors-only---gsk-4695849)
- 2023-06-16 20:21 UTC [SEC Form 6-K] [SEC Form 6-K filed by BELLUS Health Inc.](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-bellus-health-inc-4653602)
- 2023-06-16 17:50 UTC [BELLUS Health Inc. Announces Voting Results from Special Meeting of Shareholders](https://www.quantisnow.com/insight/bellus-health-inc-announces-voting-results-from-special-meeting-of-4652417)
- 2023-06-06 20:05 UTC [SEC Form 6-K] [SEC Form 6-K filed by BELLUS Health Inc.](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-bellus-health-inc-4609635)
- 2023-06-02 20:25 UTC [SEC Form 6-K] [SEC Form 6-K filed by BELLUS Health Inc.](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-bellus-health-inc-4597291)
- 2023-05-19 21:27 UTC [SEC Form 6-K] [SEC Form 6-K filed by BELLUS Health Inc.](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-bellus-health-inc-4534882)
- 2023-05-16 21:04 UTC [SEC Form 6-K] [SEC Form 6-K filed by BELLUS Health Inc.](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-bellus-health-inc-4515879)
- 2023-05-16 21:01 UTC [Conference Announcement] [BELLUS Health Inc. Calls Special Shareholders' Meeting in Connection with GSK Acquisition](https://www.quantisnow.com/insight/bellus-health-inc-calls-special-shareholders-meeting-in-connection-with-4515782)
- 2023-05-15 12:43 UTC [Market Insight] [RBC Capital Reiterates Sector Perform on BELLUS Health, Maintains $14.75 Price Target](https://www.quantisnow.com/insight/rbc-capital-reiterates-sector-perform-on-bellus-health-maintains-1475-4501028)
- 2023-05-12 21:05 UTC [Market Insight] [BELLUS Health: Q1 Earnings Insights](https://www.quantisnow.com/insight/bellus-health-q1-earnings-insights-4497817)
- 2023-05-12 20:32 UTC [SEC Form 6-K] [SEC Form 6-K filed by BELLUS Health Inc.](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-bellus-health-inc-4497280)
- 2023-05-12 20:04 UTC [Market Insight] [BELLUS Health Q1 EPS $(0.20) Misses $(0.18) Estimate, Sales $3.00K Down From $4.00K YoY](https://www.quantisnow.com/insight/bellus-health-q1-eps-020-misses-018-estimate-sales-300k-4496412)
- 2023-05-12 20:02 UTC [SEC Form 6-K] [SEC Form 6-K filed by BELLUS Health Inc.](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-bellus-health-inc-4496354)
- 2023-05-12 20:01 UTC [BELLUS Health Reports First Quarter 2023 Financial Results and Business Highlights](https://www.quantisnow.com/insight/bellus-health-reports-first-quarter-2023-financial-results-and-business-4496282)
- 2023-04-28 19:01 UTC [SEC Form 6-K] [SEC Form 6-K filed by BELLUS Health Inc.](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-bellus-health-inc-4409734)
- 2023-04-28 15:13 UTC [SEC Form 6-K] [SEC Form 6-K filed by BELLUS Health Inc.](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-bellus-health-inc-4406799)
- 2023-04-27 10:04 UTC [SEC Form 6-K] [SEC Form 6-K filed by BELLUS Health Inc.](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-bellus-health-inc-4393110)
- 2023-04-26 22:00 UTC [SEC Form 6-K] [SEC Form 6-K filed by BELLUS Health Inc.](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-bellus-health-inc-4392878)
- 2023-04-26 22:04 UTC [Market Insight] [BELLUS Health Announces Meeting Updates; Says Record Date For Meeting Will Be May 15, 2023 For Vote $2B GSK Acquisition](https://www.quantisnow.com/insight/bellus-health-announces-meeting-updates-says-record-date-for-meeting-4392105)
- 2023-04-26 22:00 UTC [BELLUS Health Announces Meeting Updates](https://www.quantisnow.com/insight/bellus-health-announces-meeting-updates-4392090)
- 2023-04-24 23:05 UTC [SEC Form 6-K] [SEC Form 6-K filed by BELLUS Health Inc.](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-bellus-health-inc-4376483)
- 2023-04-19 15:00 UTC [Market Insight] [Benzinga's Top Ratings Upgrades, Downgrades For April 19, 2023](https://www.quantisnow.com/insight/benzingas-top-ratings-upgrades-downgrades-for-april-19-2023-4355198)
- 2023-04-19 14:01 UTC [Market Insight] [Where BELLUS Health Stands With Analysts](https://www.quantisnow.com/insight/where-bellus-health-stands-with-analysts-4354819)
- 2023-04-19 13:30 UTC [Market Insight] [RBC Capital Downgrades BELLUS Health to Sector Perform, Lowers Price Target to $14.75](https://www.quantisnow.com/insight/rbc-capital-downgrades-bellus-health-to-sector-perform-lowers-price-4354527)
- 2023-04-19 13:15 UTC [Market Insight] [Jefferies Downgrades BELLUS Health to Hold, Lowers Price Target to $14.75](https://www.quantisnow.com/insight/jefferies-downgrades-bellus-health-to-hold-lowers-price-target-to-4354422)
- 2023-04-19 12:02 UTC [Analyst Downgrade] [BELLUS Health downgraded by RBC Capital Mkts](https://www.quantisnow.com/insight/bellus-health-downgraded-by-rbc-capital-mkts-4353606)
- 2023-04-18 18:31 UTC [Market Insight] [Dow Edges Higher; Goldman Sachs Posts Upbeat Earnings](https://www.quantisnow.com/insight/dow-edges-higher-goldman-sachs-posts-upbeat-earnings-4350095)
- 2023-04-18 17:14 UTC [Market Insight] [Why Glory Star New Media Group Shares Are Trading Higher By 122%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session](https://www.quantisnow.com/insight/why-glory-star-new-media-group-shares-are-trading-higher-4349696)
- 2023-04-18 16:18 UTC [Market Insight] [GSK Reaches Agreement To Acquire Late-Stage Biopharmaceutical Company Bellus Health; The Transaction Remains Subject To Regulatory Approvals; No Financial Terms Disclosed](https://www.quantisnow.com/insight/gsk-reaches-agreement-to-acquire-late-stage-biopharmaceutical-company-bellus-health-4349425)
- 2023-04-18 16:11 UTC [GSK reaches agreement to acquire late-stage biopharmaceutical company BELLUS Health](https://www.quantisnow.com/insight/gsk-reaches-agreement-to-acquire-late-stage-biopharmaceutical-company-bellus-health-4349404)
- 2023-04-18 16:01 UTC [Market Insight] [Dow Dips Over 100 Points; Bank of America Earnings Beat Estimates](https://www.quantisnow.com/insight/dow-dips-over-100-points-bank-of-america-earnings-beat-4349375)
- 2023-04-18 15:00 UTC [Market Insight] [Benzinga's Top Ratings Upgrades, Downgrades For April 18, 2023](https://www.quantisnow.com/insight/benzingas-top-ratings-upgrades-downgrades-for-april-18-2023-4348984)

## More

- Live page with ratings, short volume, options and peers: https://www.quantisnow.com/company/BLU
- Earnings history: https://www.quantisnow.com/earnings/BLU
- Dividend history: https://www.quantisnow.com/dividends/BLU
- Insider transactions: https://www.quantisnow.com/insiders/BLU
- Options chain: https://www.quantisnow.com/options/BLU
- SEC 8-K filings only: https://www.quantisnow.com/company/BLU/8-k
- RSS and alerts for BLU: https://www.quantisnow.com/docs/rss-feeds.md
